Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine co-induction for MDD in gynecologic surgery
NCT03666494Phase 4Unknown
- Sponsor
- University of Saskatchewan
- Start
- Dec 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ketamine in major depressive disorder (MDD), sponsored by University of Saskatchewan. Status: unknown.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT03666494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666494.